Brain Tumours

Brain tumours are abnormal cell growths that can be benign (non-cancerous) or malignant (cancerous). Their distinctive difficulties include early detection and treatment issues, mainly when the blood-brain barrier's protective function limits several medications. Therapy can also significantly negatively influence the cardiovascular system. Along with developing medicines capable of breaching the blood-brain barrier, improving neurological imaging techniques for early detection is essential to improving outcomes for patients with brain tumours.

+1-571-5561014
Phone
cancer@precisionglobalconferences.com
Mail to us
Miami, Florida, USA Address

2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Brain Tumours

Related Sessions

Current Landscape and Future Directions of Oncology Research

Oncogenic Signaling Pathways and Therapeutic Targets

Emerging Biomarkers for Cancer Detection and Prognosis

Cancer Prevention and Early Detection Strategies

Immuno-Oncology and Cell-Based Therapies

Innovations in Immuno-Oncology

Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy: Clinical Progress and Challenges

Next-Generation Cell and Gene Therapies in Oncology

Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics

Companion Diagnostics

Artificial Intelligence and Machine Learning in Precision Oncology

Next-Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS

Overcoming Drug Resistance: Mechanisms and Solutions

Oncology Pipeline

Trends in Antibody–Drug Conjugates (ADCs)

Launch of Novel mAb Products for Cancer Therapy

Useful Links

Venue Details

Precision Global Conferences